Gina Brockenbrough - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Gina Brockenbrough's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Gina Brockenbrough

Gina Brockenbrough

Verified

Managing Editor, Orthopedics Today

Philadelphia

Final Covers

History, War Health Geopolitics, CensorshipPolitics, Tech

Journalist Type

-

Seniority Positions

Medium Formats

-

Content

Total articles 2241

  • Cardiovascular death risk increases with cardiovascular-kidney-metabolic syndrome stage

    By Shawn M. Carter Verified, Gina Brockenbrough Verified| Nephrology News & Issues Verified Key takeaways: Risk for cardiovascular death increased with disease stage, but risk was similar for stages 0 and 1. Survival time was reduced by about 8.1 months for stage 4 vs. stage 0. Higher stages of cardiovascular-kidney-metabolic syndrome may correlate to increased risk of cardiovascular mortality, according to a longitudinal study of U.S. adults.

    By Shawn M. Carter Verified, Gina Brockenbrough Verified · Nephrology News & Issues

    Apr. 01, 2025

  • Q&A: ‘A lot of opportunity’ exists to educate patients on hemodialysis about cannabis use

    By Jill Rollet Verified, Gina Brockenbrough Verified| Nephrology News & Issues Verified Read more Key takeaways: More than 20% of patients on hemodialysis reported cannabis use, but only 8% had ever been asked about it. Cannabis does not interfere with dialysis but could interact with drugs used by this population. Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.

    By Jill Rollet Verified, Gina Brockenbrough Verified · Nephrology News & Issues

    Apr. 01, 2025

  • Cardiovascular death risk increases with cardiovascular-kidney-metabolic syndrome stage

    By Shawn M. Carter Verified, Gina Brockenbrough Verified| Nephrology News & Issues Verified Key takeaways: Risk for cardiovascular death increased with disease stage, but risk was similar for stages 0 and 1. Survival time was reduced by about 8.1 months for stage 4 vs. stage 0. Higher stages of cardiovascular-kidney-metabolic syndrome may correlate to increased risk of cardiovascular mortality, according to a longitudinal study of U.S. adults.

    By Shawn M. Carter Verified, Gina Brockenbrough Verified · Nephrology News & Issues

    Apr. 01, 2025

As seen in

Company Info

Orthopedics Today

Fort Worth and Mansfield Orthopedic Injury Clinic - Call For Same Day Appointment

Philadelphia, United States

+1 817-423-2329